Announcement

A Patent Cell has been set up to facilitate the processing and filing of  patents by inventors working at AIIMS.

Inventors who wish to patent their invention are required to furnish details in the Invention Disclosure Format which can be downloaded from the AIIMS website (www.aiims.ac.in).

The applications will be assessed for feasibility by a committee comprising of members of the patent cell and experts, before the inventors can meet with the patent attorney^* for filing of the patent.

Ten copies of the application in the prescribed format should be submitted to Mr. E. Lakra, Member-Secretary, Patent Cell.

IMPORTANT

Before sending a request for patenting, the inventors must make sure that the invention fulfils the following three criteria for patent ability:

• Novelty
• Inventive step
• Use or application

They must also be able to produce the record of the steps involved in the invention.

For further clarifications, please contact Patent Cell, Tel. No. 26593741, E mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

*Patent Attorney

M/s L S Davar & Co.

5/1, (1^st Floor) Kalkaji Extn.

New Delhi – 110 019

Tel: 2641 8980, 2643 8162, 2623 2328

Fax: 91-11-2923 4443, 2646 4498, 4143 1140

E-mail:  This email address is being protected from spambots. You need JavaScript enabled to view it.

Medical Social & Welfare Services

National Pharmacovigilance Programme

The nation wide programme, sponsored and coordinated by the country’s central drug regulatory agency – Central Drugs Standard Control Organization (CDSCO) – to establish and manage a data base of Adverse Drug Reactions (ADR) for making informed regulatory decisions regarding marketing authorization of drugs in India for ensuring safety of drugs. 

The National Pharmacovigilance Centre at CDSCO coordinates the programme. The National Centre will operate under the supervision of the National Pharmacovigilance Advisory Committee (NPAC) to recommend procedures and guidelines for regulatory interventions.  

Objectives of the Programme

Broad objectives of the Programme

• To foster the culture of AE notification and reporting
• To establish a viable and broad-based ADR monitoring program in India

Specific objectives of the Programme

• To create an ADR database for the Indian population
• To create awareness of ADR monitoring among people
• To ensure optimum safety of drug products in Indian market
• To create infrastructure for ongoing regulatory review of PSURs

The National Pharmacovigilance Advisory Committee (NPAC) will oversee the performance of various Zonal, Regional and Peripheral Centres and will perform the functions of “Review Committee” for this program. The NPAC will also recommend possible regulatory measures based on pharmacovigilance data received from various centres.

National Pharmacovigilance Programme comprises of twenty-four Peripheral Pharmacovigilance Centers pooling their data at five Regional Pharmacovigilance Centers, which in turn funnel their data to the two Zonal Pharmacovigilance Centers.

ZONAL PHARMACOVIGILANCE CENTER

Large healthcare facilities attached with medical colleges in metro cities identified by the CDSCO for the purpose. They would act as third level centres in the administrative structure of the NPPI. They will function as First contact ADE data collection units also.

Zonal Pharmacovigilance Centres to coordinate the nationwide programme. For the North-East Region Department of Pharmacology at All India Institute of Medical Sciences, New Delhi is designated as Zonal Pharmacovigilance Centre.

AIIMS Zonal Pharmacovigilance Center is engaged in collecting, analyzing the data and submit consolidated information to the National Pharmacovigilance Centre where National Pharmacovigilance Advisory Committee would evaluate the data and recommends appropriate regulatory interventions.

ADE NOTIFICATION

Process of informing by a notifier to any participating Pharmacovigilance centre about the occurrence of a suspected ADE. The process may involve informing over telephone, in person, email, fax or any other means of communication-verbal or written. All notifiers must give their contact details.

Appropriate and adequate measures must be taken to keep track of the notifier. Any follow up action will be initiated on a notification only after the due verification of the notifier. If the notifier cannot be traced back, it will be recorded on the notification slip before closing the case.

List of Pharmacovigilance Centres

Download the ADE Reporting Form

Unknown Patients Information

Speciality Centres

• Cardio-Thoracic Sciences Centre
• Nuerosciences Centre
• Dr. R.P.Centre for Opthalmic Sciences
• Dr. B.R.A.Institute-Rotary Cancer Hospital
• De-Adiction Centre
• Jai-Prakash Narayan Apex Trauma Centre

Departments

• Anaesthesiology
• Anatomy
• Biochemistry
• Biomedical Engineering
• Biophysics
• Biostatistics
• Biotechnology
• Cardiology
• Centre for Community Medicine
• College of Nursing
• Dental Surgery
• Dermatology &amp Venereology
• Endocrinology, Metabolism &amp diabetes
• Forensic Medicine
• Gasteroenterology &amp Human Nutrition
• Gastrointestinal Surgery
• Haematology
• Hospital Administration
• Laboratory Medicine
• Medicine
• Microbiology
• Nepherology
• Nuclear Medicine
• Nuclear Medicine Resonance Imaging
• Obstetrics &amp Gynaecology
• Orthopaedics
• Otorhinolaryngology
• Paediatrics
• Paediatric Surgery
• Pathology
• Pharmacology
• Physiology
• Physical Medicine &amp Rehablitation
• Psychiatry
• Radiodiagnosis
• Reproductive Biology
• Surgical Disciples
• Transplant Immunology &amp Immunogenetics
• Transfusion Medicine (Blood Bank)
• Urology

For further details Contact: Meenu Marwaha

M.S.S.O.

Centre

All India institute of Medical Sciences ,New Delhi

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.